PUBLISHER: Grand View Research | PRODUCT CODE: 1908250
PUBLISHER: Grand View Research | PRODUCT CODE: 1908250
The global aortic aneurysm market size was estimated at USD 5.04 billion in 2025 and is projected to reach USD 12.87 billion by 2033, growing at a CAGR of 12.59% from 2026 to 2033. The market growth is driven by the increasing prevalence of aortic aneurysms, fueled by aging populations and common risk factors such as hypertension, smoking, and atherosclerosis.
Additionally, the growing adoption of minimally invasive endovascular repair procedures, the expansion of screening programs for early detection, and continuous advancements in stent graft technologies are all accelerating market growth. In February 2025, Czechia launched a pilot abdominal aortic aneurysm screening programme for men aged 65-67, aiming to detect AAAs early and prevent up to 100 deaths annually.
The increasing prevalence of cardiovascular disease among older populations drives demand in the aortic aneurysm industry. The incidence of abdominal aortic aneurysms (AAA) is increased by obesity, smoking, and high blood pressure. The need for endovascular and surgical procedures for screening, diagnosis, and intervention is increasing for healthcare systems. In September 2024, according to Medscape, AAA prevalence in the U.S. ranged from 0.5% to 3.2%, with ruptures causing approximately 15,000 deaths annually; globally.
Treatment options are being enhanced by developments in thoracic endovascular aneurysm repair (TEVAR) and endovascular aneurysm repair (EVAR). Flexibility, deployment precision, and compatibility with complex structures are all enhanced by new stent graft designs. Physician adoption of these devices is growing steadily, and they accelerate recovery and reduce complications. In November 2024, Bentley reported that its BeFlared bridging stent for FEVAR was effectively implanted, reducing procedure time and preserving artery blood flow.
Screening and prevention programs are increasing diagnosis rates. National AAA screening efforts in Europe and North America, combined with wider use of ultrasound and CT angiography, are enabling earlier detection in high-risk groups. This drives timely treatment, lowers rupture-related mortality, and sustains demand for surgical and endovascular solutions. In September 2025, using quick ultrasounds to identify aneurysms early, stop ruptures, and enhance outcomes for the 20,000 Canadians affected each year, Ontario started the country's first AAA screening program for people 65 and older.
Advances in Endovascular Aneurysm Repair Technology
New technologies for endovascular techniques for abdominal aortic aneurysm repair (EVAR) continue to be tested to enhance patient safety, lower complications, and lower the rate of reintervention. To enhance clinical results and supplement current endografts, innovations such as aneurysm sac sealing devices are being developed. In July 2024, Life Seal Vascular Inc. received an SBIR grant from the National Science Foundation for the research and development of an EVAR technology that can cover the aneurysmal sac, minimize endoleaks, and enhance the success of the procedure.
Expansion of Dedicated Aortic Care Facilities
Specialized centers for aortic disease are increasingly being established to address the growing burden of aneurysms, dissections, and related conditions. These centers improve early diagnosis and provide comprehensive surgical and endovascular treatment.
In September 2024, Fortis Escorts Heart Institute, Okhla, reported that around 300,000-400,000 individuals in India experience various aortic disorders annually, while only about 1,000 receive specialized treatment, emphasizing the importance of early diagnosis and timely intervention.
Selling Prices of Aortic Aneurysm Devices
Aortic device selling prices are affected by a variety of operational, clinical, and technological factors. For instance, endovascular stent grafts are more complex as they require specialized materials, precise engineering, and a substantial amount of research and development for designs that are branched, fenestrated, or patient-specific. Standardized, surgical grafts maintain a balance between durability, demonstrated clinical results, and cost-effectiveness.
Market factors, including supply chain concerns, legal compliance, and the cost of advanced manufacturing techniques, significantly influence price levels. In healthcare settings, procurement strategies and perceived value are influenced by clinical demand patterns, procedural volumes, and the rate at which minimally invasive techniques are adopted.
Global Aortic Aneurysm Market Report Segmentation
This report forecasts revenue growth and provides at the global, regional, and country levels an analysis of the latest trends in each of the sub-segments from 2021 to 2033. For this report, Grand View Research has segmented the global aortic aneurysm market report based on type, treatment, product, end use, and region: